Fig. 1: CDH17 and GUCY2C are co-expressed at high levels in colorectal cancer. | Cell Death Discovery

Fig. 1: CDH17 and GUCY2C are co-expressed at high levels in colorectal cancer.

From: Development of a bispecific CDH17-GUCY2C ADC bearing the ferroptosis inducer RSL3 for the treatment of colorectal cancer

Fig. 1

A Expression of RNA transcription of CDH17 and GUCY2C in the GEPIA cancer tissue sample database. B CDH17 and GUCY2C are co-expressed at high levels in colon adenocarcinoma (COAD) and rectum adenocarcinoma (READ). Tumor samples are shown in red, normal samples are shown in gray, and the corresponding sample numbers are indicated. The correlation analysis results also indicate that CDH17 and GUCY2C are highly expressed concurrently in the tumors of the majority of patients. C Relative RNA expression of CDH17 and GUCY2C in different tumor cell lines. RNA from 13 tumor cells was isolated, and the expression of CDH17 and GUCY2C was detected by RT-PCR.

Back to article page